← FDA Drug Approvals (Drugs@FDA)
IBANDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX INC · Approved 2012-03-19
Drug application
- FDA Application #
ANDA078948
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBANDRONATE SODIUM
- Generic name
- IBANDRONATE SODIUM
- Active ingredients
- IBANDRONATE SODIUM
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- APOTEX INC
- Manufacturer
- Apotex Corp
- First approval
- 2012-03-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown